FDA Drug Safety Podcasts

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis

Listen Later
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
...more
View all episodesView all episodes
Download on the App Store
FDA Drug Safety PodcastsBy U.S. Food and Drug Administration, Center for Drug Evaluation and Research
  • 5
  • 5
  • 5
  • 5
  • 5

5

5 ratings